Aneusomy of chromosome 18 is associated with the development of colorectal carcinoma

Journal of Gastroenterology

Volumn 32, Issue 4, 1997, Pages 487-491

  Nanashima, Atsushi ^a   Tagawa, Yutaka ^a   Yasutake, Toru ^a   Sawai, Terumitsu ^a   Tuji, Takashi ^a   Sasano, Osamu ^a   Nakagoe, Tohru ^a   Ayabe, Hiroyoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Chromosome 18; Colorectal cancers; Fluorescence in situ hybridization; Numerical aberrations

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME 18; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CARCINOMA; DIAGNOSTIC VALUE; DISOMY; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MONOSOMY; POLYSOME; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 0030754254     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02934087     Document Type: Article

References (31)

1. Vogelstein B, Fearon ER, Hamfiton SR, et al. Genetic alterations during colorectal-tumor development. New Engl J Med 1988; 319:525-532.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
3. Ookawa K, Sakamoto M, Hirohashi S, et al. Concordant p53 and DCC alteration and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer 1993;53:382-387.
4. Kern SE, Fearon ER, Tersmette KW, et al. Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 1989;261:3099-3103.
5. Iino H, Fukuyama M, Maeda Y, et al. Molecular genetics for clinical management of colorectal carcinoma; 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 1994;73:1324-1331.
6. Bomme L, Bardi G, Pandis N, et al. Clonal karyotypic abnormalities in colorectal adenomas: Clues to the early genetic events in the adenomacarcinoma sequence. Genes Chrom Cancer 1994;10:190-196.
7. Muleris M, Zafrani B, Validire P, et al. Cytogenetic study of 30 colorectal adenomas. Cancer Genet Cytogenet 1994;74:104-108.
8. Bardi G, Sukhikh T, Pandis N, et al. Karyotypic characterization of colorectal adenocarcinomas. Genes Chrom Cancer 1995;12:97-109.
9. Cremer T, Lichter P, Borden J, et al. Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum Genet 1988;80:235-246.
10. Gray JW, Pinkel D. Molecular cytogenetics in human cancer diagnosis. Cancer 1992;69:1536-1542.
11. Tagawa Y, Sawai T, Nakagoe T, et al. Numerical aberrations of chromosome 11 and 17 in colorectal adenocarcinomas. Surgery Today 1996;26:869-874.
12. Steiner MG, Harlow SP, Colombo E, et al. Chromosome 8, 12, and 17 copy number in Astler-Coller stage C colon cancer in relation to proliferative activity and DNA ploidy. Cancer Res 1993;53:681-686.
13. Chen TR, Nierman WC. Chromosome painting and quantitative karyotyping of colon adenocarcinoma cell lines, DLD-1 and HCT-15. Anticancer Res 1994;14:109-112.
14. Pinkel D, Landeqent J, Collins C, et al. Fluorescence in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci USA 1988;85:9138-9142.
15. Eastmond DA, Pinkel D. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutation Res 1990;234:303-318.
16. Berger CS, Sandberg AA, Todd IAD, et al. Chromosomes in kidney, ureter, and bladder cancer. Cancer Genet Cytogenet 1986;23:1-24.
17. Pandis N, Jin Y, Gorunova L, et al. Chromosome analysis of 97 primary carcinomas of the breast: Identification of eight karyotypic subgroups. Genes Chrom Cancer 1995;12:173-185.
18. Vinci AD, Infusini E, Peveri C, et al. Deletions at chromosome 1p by fluorescence in situ hybridization are an early event in human colorectal tumorigenesis. Gastroenterol 1996;111:102-107.
19. Herbergs J, de Bruine AP, Marx PTJ, et al. Chromosome aberrations in adenomas of the colon. Proof of trisomy 7 in tumor cells by combined interphase cytogenetics and immunocytochemistry. Int J Cancer 1994;57:781-785.
20. Morinaga M, Tagawa Y, Yasutake Y, et al. Detection of chromosomal numerical aberration in early colorectal carcinomas using fluorescence in situ hybridization (in Japanese with English abstract). Jpn J Cancer Chemother 1994;21:75-81.
21. Pandis N, Jin Y, Gorunova L, et al. Chromosome analysis of 97 primary carcinomas of the breast: Identification of eight karyotypic subgroups. Genes Chrom Cancer 1995;12:173-185.
22. Riccardi VM, Elder DW. Multiple cytogenetic aberrations in neurofibrosarcomas complicating neurofibromatosis. Cancer Genet Cytogenet 1986;23:199-209.
23. Hahn SA, Hoque AT, Moskaluk CA, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-353.
24. Yamaguchi H. Analysis of numerical chromosome aberration of gastric cancer: Application of fluorescent in situ hybridization using chromosome specific DNA probes. Acta Med Nagasaki 1990;37:163-170.
25. Kimura H, Kagawa K, Deguchi T, et al. Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe. Cancer 1996;77:271-277.
26. Quian J, Bostwick DG, Takahashi S, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55:5408-5414.
27. Sasaki K, Sato T, Kurose A, et al. Monosomy of chromosome 18 detected by fluorescence in situ hybridization in colorectal tumors. Cancer 1995;76:1132-1138.
28. Nanashima A, Tagawa Y, Morinaga M, et al. Quantitative analysis of numerical chromosome aberrations in various morphological types of colorectal carcinomas. Jpn J Gastroenterol, 1996;31:793-800.
29. Nanashima A, Tagawa Y, Yasutake T, et al. Deletion of chromosome 11 and deveiopment of colorectal carcinoma. Cancer Detect Prev 1997;20:7-11.
30. Bardi G, Johansson B, Pandis N, et al. Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features. Cancer 1993;71:306-391.
31. Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterol 1992;102:1136-1141.